Esperion Therapeutics
Antonio M. Gotto, Jr., has been a member of Esperion’s Board of Directors since 2014. Dr. Gotto is Dean Emeritus at Weill Cornell Medicine and Provost for Medical Affairs Emeritus at Cornell University.
Antonio currently serves as a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences. He is also the current president of the National Lipid Association. From 1997 to 2011, he served as the Stephen and Suzanne Weiss Dean of the Joan and Sanford I. Weill Medical College of Cornell University and Provost for Medical Affairs of Cornell University. Previously, Antonio served as J.S. Abercrombie Chair of Atherosclerosis and Lipoprotein Research and Chairman and Professor of the Department of Medicine at Baylor College of Medicine and Methodist Hospital. He is also a past president of the International Atherosclerosis Society and a past president of the American Heart Association. Antonio was a member of the board of directors of Aegerion Pharmaceuticals, Inc. until 2016, when it merged to form Novelion Therapeutics, Inc.
Antonio holds a Bachelor of Arts degree from Vanderbilt University, a Doctor of Philosophy degree in Biochemistry from Oxford University in England, where he was a Rhodes Scholar, and a Doctor of Medicine from Vanderbilt University School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.